Ocular gene therapy

Details for Australian Patent Application No. 2003258675 (hide)

Owner Novartis AG

Inventors Campochiaro, Peter Anthony; Kaleko, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2003258675

PCT Number PCT/EP03/09497

PCT Pub. Number WO2004/020469

Priority 60/406,470 28.08.02 US

Filing date 27 August 2003

Wipo publication date 19 March 2004

Acceptance publication date 26 March 2009

International Classifications

A61K 38/39 (2006.01) Medicinal preparations containing peptides - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)

Event Publications

13 November 2003 Complete Application Filed

  Priority application(s): 60/406,470 28.08.02 US

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2003258675

26 March 2009 Application Accepted

  Published as AU-B-2003258675

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003258676-DEVICE AND METHOD FOR CONDUCTING A MONEY DEPOSIT TRANSACTION

2003258674-Ankle-joint endoprosthesis